DGFT’s extension of PSIAs validity to ease pharma foreign trade concerns in Red Sea region

In a move aimed at ensuring the stability and efficiency of pharma foreign trade operations, the Directorate General of Foreign Trade (DGFT) has extended the recognition of Pre-Shipment Inspection Agencies (PSIAs) in response to the heightened geopolitical tensions and recognizing the crucial role of the Red Sea region in international trade.

This crucial decision communicated through Public Notice No. 37/2023-DGFT comes against the backdrop of escalating geopolitical tensions affecting trade routes in the Red Sea region. The extension is specifically applicable to PSIAs completing their original three-year tenure as of December 27, 2023, effectively pushing the validity up to March 31, 2024.

The Red Sea region is of paramount importance in global trade, serving as a vital maritime corridor connecting Europe, the Middle East, and Asia. The DGFT’s move considers the heightened sensitivities in this geopolitical hotspot, aiming to ease concerns and maintain the integrity of trade practices.

In a detailed analysis of the Public Notice, it becomes evident that the extension serves as a pragmatic response to the challenges posed by geopolitical tensions. By allowing PSIAs to continue their operations smoothly, the DGFT ensures the uninterrupted flow of pre-shipment inspections, a critical aspect of international trade transactions.

The effects of this decision are not confined to India alone; it has global implications. As the Red Sea region remains a key trade route, disruptions in this area could reverberate throughout the international trade network. DGFT’s forward-looking decision mitigates potential disruptions and showcases India’s commitment to fostering stable and efficient global pharma trade practices.

“The extension from December 27, 2023, to March 31, 2024, provides relief to the listed PSIAs and businesses relying on their services, aligning with the overarching goal of promoting hassle-free foreign trade. DGFT’s role as the regulatory authority is particularly crucial in safeguarding the interests of businesses navigating the challenges posed by geopolitical tensions,” according to an international trade expert.

According to an official, “This extension is not merely a bureaucratic procedure but a strategic move by the government to support businesses and maintain the integrity of pre-shipment inspection processes. It underscores India’s commitment to facilitating a conducive environment for foreign trade amid dynamic and challenging global scenarios, especially in regions as geopolitically sensitive as the Red Sea. Businesses navigating the complexities of international trade will benefit from this extension, fostering smoother transactions until March 31, 2024”.

Related Posts

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

New Delhi:  The National Pharmaceutical Pricing Authority (NPPA) has notified retail price of 42 new drugs under the provisions of the Drugs Prices Control Order (DPCO), 2013, including anti hypertensive,…

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

New Delhi– In a landmark development for global child health, the World Health Organization (WHO) has granted prequalification to Coartem® Baby (artemether-lumefantrine), the first and only antimalarial medicine specifically developed…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

FIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged Documents

FIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged Documents

Laughing all the Way to Health with Sir Ganga Ram Hospital

Laughing all the Way to Health with Sir Ganga Ram Hospital

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop